Targeted Theranostic Nanoparticles for Brain Tumor Treatment

The poor prognosis and rapid recurrence of glioblastoma (GB) are associated to its fast-growing process and invasive nature, which make difficult the complete removal of the cancer infiltrated tissues. Additionally, GB heterogeneity within and between patients demands a patient-focused method of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Maria, Sousa, João José, Pais, Alberto, Vitorino, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321593/
https://www.ncbi.nlm.nih.gov/pubmed/30304861
http://dx.doi.org/10.3390/pharmaceutics10040181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321593/
https://www.ncbi.nlm.nih.gov/pubmed/30304861
http://dx.doi.org/10.3390/pharmaceutics10040181

Ejemplares similares